MUSTANG BIO, INC. Operating Lease Liability
MUSTANG BIO, INC. (MBIO) had Operating Lease Liability of $0 as of 2025-12-31, per its 10-K filed 2026-03-19.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2026-03-19
- 2025-12-31: Operating Lease, Liability $0.00.
- 2025-09-30: Operating Lease, Liability $0.00.
- 2025-06-30: Operating Lease, Liability $0.00.
- 2025-03-31: Operating Lease, Liability $0.00.
| Period end | Operating Lease, Liability | Operating Lease, Liability as first filed |
|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-19 | |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-08 | |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $900.00K 10-K · filed 2026-03-19 | $878.00K 10-K · filed 2025-03-28 |
| 2024-09-30 | $983.00K 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $1.08M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $2.40M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $2.50M 10-K · filed 2025-03-28 | $2.50M 10-K · filed 2024-03-11 |
| 2023-09-30 | $2.58M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $2.65M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $3.90M 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $3.90M 10-K · filed 2024-03-11 | $3.95M 10-K · filed 2023-03-30 |
| 2022-09-30 | $3.99M 10-Q · filed 2022-11-14 | |
| 2022-06-14 | $2.20M 10-K · filed 2025-03-28 | |
| 2021-12-31 | $2.00M 10-K · filed 2023-03-30 | $2.03M 10-K · filed 2022-03-23 |
| 2021-03-31 | $2.16M 10-Q · filed 2021-05-14 | |
| 2020-12-31 | $2.20M 10-K · filed 2022-03-23 | $2.23M 10-K · filed 2021-03-24 |
| 2020-09-30 | $2.29M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $2.35M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $2.42M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $2.10M 10-K · filed 2020-03-16 | |
| 2019-09-30 | $2.15M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $2.02M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $2.01M 10-Q · filed 2019-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |